Bioporto CEO holds Covid-19 test at arm's length: "Could be everything or nothing"
Bioporto CEO Peter Mørch Eriksen won't realize the diagnostics firm's hope of a Covid-19 home test – until the sensitivity of the product sets itself significantly apart from other tests in the market.
BY ULRICH QUISTGAARD, TRANSLATED BY NIELSINE NIELSEN
The Covid-19 pandemic and the world-spanning battle against it have delayed the California studies in which Danish diagnostics company Bioporto has been testing a quick saliva test for coronavirus, which people would ideally be able to bring home with them.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
